DIN 02484013 — BRINEURA 150 MG
BRINEURA is a solution of Cerliponase alfa marketed by BIOMARIN INTERNATIONAL LIMITED. The full Cerliponase alfa monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02484013
- Brand name
- BRINEURA
- Active ingredient
- Cerliponase alfa
- Strength
- 150 MG
- Dosage form
- SOLUTION
- Route
- INTRACEREBROVENTRICULAR
- Manufacturer
- BIOMARIN INTERNATIONAL LIMITED
- Health Canada status
- MARKETED
- Drug class
- Enzyme replacement therapy (recombinant tripeptidyl peptidase-1)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.